Clinical OMICS

NOV-DEC 2018

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link: https://clinicalomics.epubxp.com/i/1040438

Contents of this Issue

Navigation

Page 3 of 51

HTG Molecular Diagnostics, Inc. 3430 E. Global Loop, Tucson, AZ 85706 Call 877-289-2615 For Research Use Only. Not for use in diagnostic procedures. In the U.S. and other applicable jurisdictions, HTG EdgeSeq is a trademark of HTG Molecular Diagnostics, Inc. Any other trademarks or trade names used herein are the intellectual property of their respective owners. Partnerships: personalized HTG is committed to advancing precision medicine. HTG is an NGS-based molecular profiling company that is dedicated to supporting and improving your research outcomes, every step of the way—from translational research through clinical drug development and commercial deployment. HTG EdgeSeq technology enables fast, reproducible, and quantitative analysis of gene expression profiles using a very small amount of sample to accelerate discovery, support translational applications, and evaluate target biomarkers for companion diagnostics. To learn more about our mRNA and miRNA profiling assays, visit www.htgmolecular.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - NOV-DEC 2018